January 9, 2017
Celyad’s patent holds up after being challenged by third party
U.S. Patent and Trade Office (USPTO) has decided to uphold Celyad’s U.S. Patent No. 9,181,527, relating to allogeneic human primary…
Pharmaceuticals, Biotechnology and Life Sciences
Category: Europe
January 9, 2017
Why study Bioscience?
Author: Anna Michael, The Study Abroad Portal The Study Abroad Portal helps students worldwide to make the right decision with…
January 9, 2017
Ipsen buys Merrimack’s oncology assets
Ipsen has acquired global oncology assets from Merrimack Pharmaceuticals. This acquisition includes Merrimack’s key marketed product Onivyde (irinotecan liposome injection)…
January 9, 2017
e-Therapeutics finds CEO in Amgen
e-Therapeutics plc, the drug discovery company, has made further steps in transitioning its business as it picked Amgen Inc.’s Corporate Development Executive Director, Dr. Raymond Barlow as its new Chief Executive Officer (CEO) who assume his position before May 1, 2017.
January 9, 2017
AB Sciences’ masitinib gets new validations
AB Sciences has more reasons to believe that its protein kinase inhibitor (PKI) masitinib could have FDA’s further clearence, as the results from the pivotal phase 3 study have been published in highly regarded independent general medical journal, The Lancet.
January 6, 2017
Shield’s iron deficiency anaemia drug kicks off well in Europe
Shield Therapeutics said it was encouraged by the the demand of its its recently approved product for the treatment of iron…
January 6, 2017
GHG wraps up ABC Pharmacy buy
Georgia Healthcare Group (GHG) has finished all the paperwork in connection with buying the fourth largest pharmaceutical retailer in Georgia, ABC Pharmacia (ABC).
January 6, 2017
INEOS Styrolution presents new materials at Pharmapack 2017
INEOS Styrolution, the global leader in styrenics, will present new product highlights and a range of new applications for the healthcare industry at Pharmapack 2017 in Paris (Paris Expo, Porte de Versailles).
January 5, 2017
Lilly mixes managers, reduces U.S. staff due to Solanezumab test fail
Eli Lilly begins new year with reorganizing its leadership structure to pursue better growth opportunities in the upcoming years. The Chief Executive Officer of Lilly, David A. Ricks, who’s new position is also one among the latest promotions, said that the changes made to pharmaceutical therapeutics and geographic business should simplify and maximize the company’s late-stage pipeline and new drugs, as well as to improve productivity.
January 5, 2017
Ceylad kicks off THINK cancer trial in Belgium, blood taken from the first patient
Celyad has started on Thursday its Therapeutic Immunotherapy with NKR-2 (THINK) trial in Belgium with the first patient giving blood.
To remind, THINK trial is an open-label Phase Ib study to assess the safety and clinical activity of multiple administrations of autologous CAR-T NKR-2 cells in seven refractory cancers.